BK2069 Biotechnology
- 4640.431
- -35.092-0.75%
ALS Therapy Market Seen Increasing to Nearly $1.3B by 2029
Agios Announced Earlier Results From Its Phase 3 ENERGIZE Study Of Mitapivat In Non-Transfusion-Dependent Thalassemia; Study Achieved Its Primary Endpoint
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today presented detailed results from the global
U.S. Drug Shortages Worsen to Reach a Decade High: Report
Novo Nordisk CEO to Testify Before Senate on Ozempic Pricing
Employee Benefits Survey Finds Marked Increase in GLP-1 Coverage
Fifth Times a Charm, But Just for the Nasdaq | Wall Street Today
Major stock indexes pulled back Friday, but the Nasdaq still climbed to a Fifth closing high.
Aptevo Therapeutics Files to Sell 6.02M Shares of Common Stock
12 Health Care Stocks Moving In Friday's After-Market Session
GainersKineta (NASDAQ:KA) shares moved upwards by 28.5% to $0.67 during Friday's after-market session. The company's market cap stands at $8.1 million. iSpecimen (NASDAQ:ISPC) stock moved upwards by 1
Marijuana Stock Movers For June 14, 2024
GAINERS:Global Hemp Group (OTC:GBHPF) shares closed up 74.00% at $0.05Elixinol Wellness (OTC:ELLXF) shares closed up 57.69% at $0.00AusCann Group Holdings (OTC:ACNNF) shares closed up 45.00% at $0.01G
Seelos Therapeutics Files to Sell 924K Shares of Common Stock for Holders
EU to Require Additional Cancer Risk Labeling on CAR T Therapies
S&P 500 Edges Lower; RH Shares Plunge After Q1 Results
U.S. stocks traded mixed toward the trading, with the Dow Jones index falling around 0.2% on Friday.The Dow traded down 0.24% to 38,554.69 while the NASDAQ rose 0.07% to 17,680.01. The S&P 500 also fe
Novavax Seeks FDA Authorization for Updated JN.1 COVID Shot
Moderna Stock Traded in the Red for Seven Straight Days
A Glimpse Into The Expert Outlook On Sarepta Therapeutics Through 9 Analysts
9 analysts have expressed a variety of opinions on Sarepta Therapeutics (NASDAQ:SRPT) over the past quarter, offering a diverse set of opinions from bullish to bearish.The following table encapsulates
Catalyst Watch: HP Enterprise Event, Walmart+ Week, Pure Storage Buzz, and Triple-witching Volatility
Ladenburg Thalmann Maintains Buy on UroGen Pharma, Raises Price Target to $53.5
Ladenburg Thalmann analyst Matthew Kaplan maintains UroGen Pharma (NASDAQ:URGN) with a Buy and raises the price target from $48 to $53.5.
Why Are EnGene Holdings Shares Trading Lower Friday?
EnGene Holdings Inc. (NASDAQ:ENGN) shares are trading lower Friday after the company, reported its financial results for the second quarter.What To Know: EnGene Holdings announced a net loss of $15.0
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of AMMO, Inc. (NASDAQ:POWW) fell sharply during Friday's session following fourth-quarter results.AMMO reported a fourth-quarter profit of 1 cent per share, compared to market expectations for
Cabaletta Bio Slips After Early Data for Lead Asset